MOTS-c
Email me when results postComparisons
ComparisonsMOTS-c vs exercise: what the peptide does that exercise doesn'tMOTS-c rises with exercise and mimics some of its signaling in mice, per Cell Metabolism 2015. Human trials comparing the two directly don't exist yet.Read guide →ComparisonsMOTS-c vs 5-amino-1MQ: what the research actually showsMOTS-c and 5-amino-1MQ get lumped together as fat-loss peptides. Here's how their biology, evidence base, and risk profile actually compare.Read guide →ComparisonsMOTS-c vs AOD-9604: two peptides that don't do the same jobMOTS-c targets mitochondrial metabolism; AOD-9604 targets fat breakdown via a growth hormone fragment. Neither has strong human trial data. Here's the actual comparison.Read guide →ComparisonsMOTS-c vs metformin: what the evidence actually supportsMetformin has decades of human trials and an FDA approval. MOTS-c has zero completed human trials. Here's the honest comparison, mechanism by mechanism.Read guide →ComparisonsMots-c vs nad+: what the research actually showsmots-c and NAD+ both target mitochondria but through different mechanisms. Here's what the rodent and cell data show, and where human evidence is thin for both.Read guide →ComparisonsMOTS-c vs SLU-PP-332: what the research actually saysMOTS-c has 2015 human-relevant Cell Metabolism data behind it. SLU-PP-332 has zero published human safety data. Here's the honest comparison.Read guide →